S-Ambes

S-Ambes Special Precautions

levamlodipine

Manufacturer:

GPO

Distributor:

GPO
Full Prescribing Info
Special Precautions
General: Since the vasodilation induced by S(-)amlodipine besylate is gradual in onset, acute hypotension has not been reported after oral administration of S(-)amlodipine.
Patients with hepatic impairment: No controlled clinical study of S(-)amlodipine has been performed in patients with hepatic impairment. Clinical studies in patients with normal liver function have shown that there is no elevation in the hepatic enzymes with the use of S(-)amlodipine. However, caution should be taken while administering S(-)amlodipine to patients with hepatic impairment.
Patients with renal impairment: No controlled clinical study of S(-)amlodipine has been performed in patients with renal impairment. Hence caution should be taken while administering S(-)amlodipine to patients with renal impairment.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in